Angels for Change (A4C) announces the pilot launch of Project GOLD (Generic Oncology Lifesaving Drugs), a new resiliency program that establishes an onshore buffer supply of six essential medications that are used to treat cancer. Project GOLD was created to offer physicians and patients stability of care during a shortage through emergency supply at leading distributors and manufacturers. A4C is participating with founding pilot members, pharmaceutical wholesalers Cencora and McKesson, and  pharmaceutical and medtech manufacturer Fresenius Kabi.

Angels for Change (A4C) announces its 2024 Change Maker of the Year Award , Lindsey Thomas, Senior Vice President of Marketing at Fresenius Kabi USA. Lindsey was recognized for her exceptional leadership, collaborative spirit, and unwavering commitment to patient care, particularly in addressing the critical  chemotherapy drug shortages during  2023 and 2024.

Angels for Change applauds Senator Kaine, Senator Cotton, Representative Spanberger, and Representative Smith for their bipartisan leadership in taking on the drug shortage crisis and advancing this vital work. We are proud to support the End Drug Shortages Act.

How Pharmaceutical Supply Chain Advancements are Meeting the Moment and Beyond panel at Milken Institute Future of Health Summit, moderated by Sarah Karlin-Smith from Citeline, with Panelists Laura Bray from Angels for Change, Shamiram Feinglass MD, MPH from Manatt, Phelps & Phillips, LLP, Kirk Kaminsky from McKesson and Vimala Raghavendran from US Pharmacopeia.

Angels for Change is proud to announce a significant milestone in Project PROTECT. Fagron Sterile Services US (FSS), a recipient of the 2023 Project PROTECT grant and a leader 503B outsourcing, has completed the Preparation and Protective phases for preservative-free Dextrose 70% injection solution. The significance of this achievement is highlighted by the recent flooding at Baxter's North Cove manufacturing site due to Hurricane Helene, which prompted the U.S. Food and Drug Administration to include Dextrose on its drug shortage list as of October 12, 2024. The strategic preparations made through Project PROTECT, Dextrose will remain accessible to vulnerable patients, especially PICU and NICU babies, amid anticipated supply chain disruptions.

Angels for Change is proud to announce the continued expansion of Project PROTECT, a pioneering initiative to mitigate drug shortages by building an onshore resilient and redundant supply of vulnerable essential medicines.

We must work to ensure ALL pediatric cancer patients have access to their life-saving medicines.

We must act together to ensure ALL patients have access to life-saving medications. Read the AMJC article and Sandoz's new report titled, "Solving America's Drug Shortage Dilemma, For Good"

Thank you USA TODAY for highlighting the unique challenges pediatric cancer patients and children's hospitals face during drug shortages. We must ensure every hospital has access to life-saving medicines to properly treat ALL pediatric cancer patients.

Read 2 new warrior stories from patients in a drug shortage crisis and explore how Angels for Change is boldly working with Champions and the Cancer Moonshot team, advocating during a Capitol Hill briefing, expanding of our team to build the supply chain of the future.

Angels for Change, the nation’s only nonprofit, patient advocacy organization dedicated to ending drug shortages, announces expansion of their team to three employees with the addition of a Chief Operating Officer (COO).

Thank you to the Journal of Clinical Pathways for interviewing Chief Change Maker, Laura Bray at the 2024 National Comprehensive Cancer Network annual conference.

Science Friday took a deep dive into the complexities of drug shortages and the patient harm they create.

Angels for Change, a nonprofit organization dedicated to ending drug shortages, hosted the fifth annual SummitONE conference on July 8 and 9 at Fresenius Kabi’s U.S. headquarters in Lake Zurich, Illinois. SummitONE is the only annual conference that gathers supply chain leaders, drug shortage experts, policy makers, and patients to discuss solutions to end drug shortages.

"It was the question of, is he gonna get what he needs? Are we even gonna be able to have the best chance at beating this?" Kristin Zastoupil mother of a Drug Shortage Warrior said.

Leap into our latest Issue 9, Quarter 2, 2024 of The Changemaker Chronicle!

“It’s very frustrating because it’s difficult to reach remission with this disease and once you find that magic combination, you want to stick with it as long as possible,” said Christina Shreeve, shortage warrior Gavin’s mother.

Angels for Change, a global non-profit on a mission to end drug shortages, presented the organization’s 2024 Drug Shortage Guardian Award to Fresenius Kabi (USA), a global health care company that specializes in lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition headquartered in Lake Zurich, IL. 

A4C releases our 2023 Annual Impact Report. This report showcases what can be achieved when Change Makers, Champions, and Patients work together to end drug shortages.

Thank you Spotlight on America and Lisa Fletcher for bringing awareness to drug shortages, Laura's work with the White House Task Force, the new HHS preventing drug shortages white paper, and the actionable steps we must take to solve this crisis.

Angels for Change (A4C) hosted their fourth annual Swim2End (S2E) Shortages on Sunday, April 28th at the YMCA Camp Christina in Riverview, FL. 

May 2nd, 2024, The News on Merit Street interviewed Chief Change Maker, Laura Bray, who shared our story and how our Shortage Crisis Line and Global Supply Sharing Network works to help patients in need of life-saving medicines.

InvestigateTV+ took an in-depth look into the drug shortage crisis, the patients impacted by shortages, and what is being done end this crisis. Thank you InvestigateTV+ for bringing awareness to drug shortages and our work.